Measuring Patient Needs and Benefits in Dermatology using the Patient Benefit Index 2.0: A Validation Study
This study investigated the validity and feasibility of the Patient Benefit Index 2.0 (PBI 2.0), a short instrument to assess patient-relevant treatment benefit. In a cross-sectional study, patients with skin diseases completed the PBI 2.0 alongside instruments on quality of life and disease-specifi...
Main Authors: | Janine Topp, Matthias Augustin, Kathrin von Usslar, Ramona Gosau, Kristian Reich, Michael Reusch, Christine Blome |
---|---|
Format: | Article |
Language: | English |
Published: |
Society for Publication of Acta Dermato-Venereologica
2018-11-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3063
|
Similar Items
-
Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review
by: Ana Babac, et al.
Published: (2019-12-01) -
Patient-relevant outcomes: what are we talking about? A scoping review to improve conceptual clarity
by: Christine Kersting, et al.
Published: (2020-06-01) -
Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management
by: Berardi R, et al.
Published: (2020-09-01) -
A Systematic Review of the Impact of Public Mental Health Benefit Changes on Patients with a Serious Mental Illness
by: Schnarr, Marjanne, et al.
Published: (2012) -
Which Benefits Are Mentioned Most Often in Drug Development Publications?
by: Vanessa Strüver, MSc
Published: (2017-01-01)